Bioactive polymethoxylated flavonoids from <i>Chiliadenus montanus</i> by Hamed, Ahmed R. et al.
                                                              
University of Dundee
Bioactive polymethoxylated flavonoids from Chiliadenus montanus
Hamed, Ahmed R.; Mohamed, Tarik A.; Tawfik, Wafaa A.; Hassan, Emad M.; Higgins,
Maureen; El-Toumy, Sayed A.; Dinkova-Kostova, Albena
Published in:
Journal of Chemical and Pharmaceutical Research
Publication date:
2016
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Hamed, A. R., Mohamed, T. A., Tawfik, W. A., Hassan, E. M., Higgins, M., El-Toumy, S. A., & Dinkova-Kostova,
A. T. (2016). Bioactive polymethoxylated flavonoids from Chiliadenus montanus. Journal of Chemical and
Pharmaceutical Research, 8(3), 788-793.
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 17. Feb. 2017
Available online www.jocpr.com 
 
Journal of Chemical and Pharmaceutical Research, 2016, 8(3):788-793                     
 
 
Research Article 
ISSN : 0975-7384 
CODEN(USA) : JCPRC5 
 
788 
Bioactive polymethoxylated flavonoids from Chiliadenus montanus 
 
Ahmed R. Hamed
1*
, Tarik A. Mohamed
1
, Wafaa A. Tawfik
1
, Emad M. Hassan
2
, Maureen 
Higgins
3
, Sayed A. El-Toumy
4
 and Albena T. Dinkova-Kostova
3
 
 
1
Chemistry of Medicinal Plants Department, National Research Centre, El Buhooth st., Dokki, Giza 12622, Egypt 
2
Medicinal and Aromatic Plants Research Department, National Research Centre, El Buhooth st., Dokki, Giza 
12622, Egypt 
3
Jacqui Wood Cancer Centre, Division of Cancer Research, School of Medicine, University 
of Dundee, Dundee, DD1 9SY, Scotland, UK 
4
Chemistry of Tannins Department, National Research Centre, El Buhooth st., Dokki, Giza 12622, Egypt 
_____________________________________________________________________________________________ 
 
ABSTRACT 
 
Phytochemical investigations of the CH2Cl2/MeOH (1:1) extract of air-dried aerial parts of Chiliadenus montanus 
afforded seven methoxylated flavonoids (1-7), three of them were isolated for the first time from the genus (1-3). 
Structures were established by spectroscopic methods, including HREIMS, 
1
H, 
13
C, DEPT, 
1
H-
1
H COSY, HMQC 
and HMBC NMR analyses. In the present study, three of the isolated compounds were tested for the ability to induce 
NAD(P)H:quinoneoxidoreductase 1 (NQO1) using a quantitative bioassay in a murine hepatoma cell line. 
Compound 1 revealed dose-dependent NQO1 inducing properties with a concentration that doubled the specific 
enzyme activity by 2-fold (CD value) of 7.0 μM, and a magnitude of induction of 3.3-fold at the highest 
concentration tested (100 μM). 
_____________________________________________________________________________________________ 
 
INTRODUCTION 
 
South Sinai is an epicenter of medicinal plants in the Arabian Desert with active plant constituents serving as a focal 
point for ecologists, taxonomists and phytochemists alike from around the globe [1-6]. Chiliadenus montanus 
(Vahl.) Brullo[=Jasonia montana, Varthemia montana (Vahl.) Boiss.], an herbendogenous to the Sinai region of 
Egypt, is a member of the Asteraceae [7], popularly known as Haneida, is common in the Sinai Peninsula. This 
medicinal plant is traditionally used for chest diseases, diarrhea, renal troubles and stomachache [8]. Moreover, 
evidences for their hypoglycemic, antioxidant and anticholestatic activities have been recently investigated [9,10]. 
Previous phytochemical researchers have identified the presence of active constituents in the aerial parts, including 
phenolic compounds that give C.montanus their medicinal values [8, 11]. 
 
C. montanus is used as a herbal tea for the treatment of renal troubles and select chemical components have been 
shown to exhibit antimicrobial, anti-diabetic, antioxidant, antiatherogenic, antibacterial, antifungal and anti-obesity 
activities [12-14]. 
 
Flavonoids are well known as antioxidant and chelating properties raised for many factors such as: (a) multiple 
hydroxyl groups which confer substantial antioxidant, chelating and prooxidant activity, (b) methoxy groups which 
increase lipophilicity and membrane partitioning, and (c) occurance of a double bond and carbonyl function 
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suggested to increases activity by affording a more stable flavonoid radical through conjugation and electron 
delocalization. Many structure-activity relationships studies for natural metabolites support these functions [15-21]. 
 
NAD(P)H: quinone oxidoreductase1 (NQO1) is a chemoprotective enzyme catalyzing the reduction and 
detoxification of exogenous quinones, and may also be involved in scavenging superoxide in cells and prevention of 
oxidative recycling. Herein, phytochemical investigations of the CH2Cl2/MeOH (1:1) metabolites of C. montans air-
dried aerial parts afforded seven polymethoxylated flavonoids (1-7), three of them are isolated for the first time from 
the genus (1-3). Structures were established by spectroscopic methods, and three of the isolated compounds 
(compounds 1, 5 and 7) were tested for NQO1 inducer activity. 
 
EXPERIMENTAL SECTION 
 
General procedures: Instrumentation included JEOL JMS-GCMATE mass spectrometer for EI-MS and HR-EI-MS; 
a JEOL JNM-ECA 600 spectrometer with tetramethylsilane as an internal standard for 1H (600 MHz) and 13C (150 
MHz) NMR spectra. The following experimental materials were used for chromatography: normal-phase silica gel 
column chromatography, silica gel BW-200 (Fuji Silysia Chemical, Ltd., 150–350 mesh); TLC, pre-coated TLC 
plates with silica gel 60F254 (Merck, 0.25 mm) (ordinary phase) and silica gel RP-18 F254 (Merck, 0.25 mm) (reverse 
phase); reverse-phase HPTLC, pre-coated TLC plates with silica gel RP-18 WF254 (Merck, 0.25 mm); and detection 
was achieved by spraying with (1:9) H2SO4-MeOH followed by heating. 
 
Plant material 
Air-dried aerial parts of Chiliadenus montanus (Vahl.) Brullo. were collected in 2013, from Wadi Gebal, North 
Sinai, Egypt. Plant material was identified by Dr. El-Bialy E. Hatab, Egyptian Environmental Affairs Agency, 
Nature Conservation Sector, Siwa Protected Area, Siwa, Egypt. A voucher specimen SK-1001 has been deposited in 
the Herbarium of Saint Catherine Protectorate, Egypt. 
 
Extraction and isolation 
Aerial parts (2.0 kg) of C. montanus were powdered and was percolated with CH2Cl2:MeOH (1:1) (10 L, 3 days x 2) 
at room temperature. The supernatants were combined and concentrated in vacuo to give a concrete (175 g), which 
was fractionated on a silica gel column (6 x 120 cm) eluting with n-hexane (3 L) followed by a gradient of n-
hexane-CHCl3 up to 100% CHCl3 and then a CHCl3–MeOH studies at up to 15% MeOH (3 L each of the solvent 
mixture) to yield 10 fractions. 
 
Fraction 4, (4.5 g) eluted with n-hexane–EtOAc (4:1) was subjected to a second silica gel column separation (120 
cm x 3 cm) to afford compounds 2 (4 mg), 5 (50 mg ),6 (7 mg) and 7 (400 mg).Fraction 5, (5.6 g) eluted with n-
hexane–EtOAc (4:1) was subjected to a second silica gel column separation (120 cm x 3 cm) to afford compounds 1 
(80 mg), 3 (6 mg ) and 4 (5 mg). 
 
5,7-Dihydroxy-3,3',4'-trimethoxyflavone (1): CI8H16O7, 
1
H NMR (600 MHz, CDCl3): 7.69 (1H, d, J = 2.0 Hz, H-2'), 
7.67 (1H, dd, J = 8.2, 2.0 Hz, H-6'), 7.00 (1H, d, J = 8.2 Hz, H-5'), 6.44 (1H, d, H-8), 6.35 (1H, d, H-6) 3.97, 3.87 
and 3.85 (9H, singlets, 3 OCH3). 
13
C NMR (125 MHz, in CDCl3):156.0 (C-2), 138.9 (C-3), 178.8 (C-4), 162.1 (C-5), 97.9 (C-6),  165.5 (C-7), 92.3 
(C-8), 156.8 (C-9), 106.1 (C-10), 122.8 (C-l`), 111.0 (C-2`), 148.4 (C-3`), 146.4 (C-4`), 114.7 (C-5`), 122.5 (C-6`), 
60.3 (3-OCH3), 56.2, 55.9 (3`-OCH3 and 4`-OCH3). 
 
5,4`-Dihydroxy-3,6,7,3`-tetramethoxyflavone (Chrysosplenetin) (2): CI9H18O8, 
1
H NMR (600 MHz, CDCl3):7.72 
(1H, dd, J = 8.4, 2.0, H-6`), 7.67 (1H, d, J = 2.0, H-2`), 6.99 (1H, d, J = 8.4, H-5`), 6.55 (1H, s, H-8), 4.00, 3.96, 
3.95 and 3.84 (12H, singlets, 4 OCH3). 
13
C NMR (125 MHz, in CDCl3): 156.0 (C-2), 138.9 (C-3), 178.9 (C-4), 153.0 (C-5), 132.3 (C-6), 158.9 (C-7), 92.4 
(C-8), 152.5 (C-9), 109.3 (C-10), 122.5 (C-1`), 110.9 (C-2`), 146.4 (C-3`), 148.5 (C-4`), 115.7 (C-5`), 122.9 (C-6`), 
60.1 (OCH3), 56.3 (OCH3), 56.1 (OCH3), 50.9 (OCH3). 
 
5,4`-Dihydroxy-3,7-dimethoxyflavone (3): CI7H14O6, 
1
H NMR (600 MHz, CDCl3):7.99 (1H, d, J = 8.80, H-2`, 6`), 
6.88 (1H, d, J = 8.90, H-3`, 5`), 6.60 (1H, s, H-8), 6.31 (1H, s, H-6), 3.87 and 3.77 (6H, singlets, 2 OCH3). 
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Centaureidin (4): CI8H16O8, 
1
H NMR (600 MHz, CDCl3): 7.67 (1H, d, J = 2.0 Hz, H-2'), 7.66 (1H, d, J = 2.0 Hz, H-
6'), 7.04 (1H, d, J = 8.2 Hz, H-5'), 6.54 (1H, s, H-8), 3.83, 3.96 and 4.02 (9H, singlets, 3 OCH3). 
13
C NMR (125 MHz, in CDCl3):152.4 (C-2), 137.9 (C-3), 178.9 (C-4), 152.4 (C-5), 131.3 (C-6), 157.4 (C-7). 93.7 
(C-8), 156.5 (C-9), 105.5 (C-10).122.3 (C-1`). 115.1 (C-2`), 147.5 (C-3`), 149.7 (C-4`), 111.5 (C-5`), 121.5 (C-6`), 
59.3, 59.7 (3-OCH3 and 6-OCH3), 55.2 (7- OCH3). 
 
5,7-Dihydroxy-3,6,3',4'-tetramethoxyflavone (bonanzin) (5): CI9H18O8, 
1
H NMR (600 MHz, CDCl3): 7.69 (1H, d, J 
= 2.0 Hz, H-2'), 7.65 (1H, dd, J = 8.2, 2.0 Hz, H-6'), 7.04 (1H, d, J = 8.2 Hz, H-5'), 6.49 (1H, s, H-8), 3.97, 3.95, 
3.91 and 3.85 (12H, singlets, 4 OCH3). 
13
C NMR (125 MHz, in CDCl3): 152.9 (C-2), 138.0 (C-3), 178.9 (C-4), 152.4 (C-5). 132.4 (C-6), 158.9 (C-7), 90.4 
(C-8), 156.1(C-9), 106.7 (C-10), 122.7(C-l`), 114.7 (C-2`), 146.4 (C-3`), 148.4 (C-4`), 111.0 (C-5`), 122.5 (C-6`) 
60.9, 60.3 (3-OCH3 and 6-OCH3), 56.4, 56.2 (7-OCH3 and 4`-OCH3). 
 
5,3`,4`-Trihydroxy-3,6,7-trimethoxyflavone(chrysosplenol-D) (6): CI8H16O8, 
1
H NMR (600 MHz, CDCl3): 7.60 (1H, 
d, J = 2.0 Hz, H-2'), 7.53 (1H, dd, J = 8.2, 2.0 Hz, H-6'), 6.92 (1H, d, J = 8.2 Hz, H-5'), 6.54 (1H, s, H-8), 3.82, 3.76 
and 3.71 (9H, singlets, 3 OCH3). 
13
C NMR (125 MHz, in CDCl3): 152.9 (C-2), 137.9 (C-3), 178.7 (C-4), 152.1 (C-5). 131.7 (C-6), 157.8 (C-7), 94.6 
(C-8), 156.1 (C-9), 105.1 (C-10), 122.7(C-l`), 116.2 (C-2`), 148.0 (C-3`), 150.3(C-4`), 112.6 (C-5`), 121.3 (C-6`) 
60.5, 60.2 (3-OCH3 and 6-OCH3) and 56.2 (4`-OCH3). 
 
5-Hydroxy-3,6,7,3`,4`-pentamethoxy flavone(artemetin) (7). C20H20O8, 
1
H NMR (600 MHz, CDCl3): 7.69 (1H, d, J 
= 2.0 Hz, H-2'), 7.66 (1H, dd, J = 8.2, 2.0 Hz, H-6'), 7.0 (1H, d, J = 8.2 Hz, H-5'), 6.49 (1H, s, H-8), 3.97, 3.95, 3.92, 
3.91 and 3.85 (15H, singlets, 5 OCH3). 
13
C NMR (125 MHz, in CDCl3): 152.8 (C-2), 138.7 (C-3), 178.9 (C-4), 152.4 (C-5), 130.5 (C-6), 158.8 (C 7), 90.4 
(C-8), 156.2 (C-9), 106.7 (C-10), 122.8 (C-l`), 115.8 (C-2`), 146.5 (C-3`), 148.5 (C-4), 114.7 (C-5`), 122.7 (C-6`), 
60.3, 60.9 (3-OCH3 and 6-OCH3) 56.4, 56.4, 56.2 (7-OCH3, 3`-OCH3 and 4`-OCH3). 
 
NQO1 inducer activity 
We employed a robust quantitative NQO1 microtiter plate bioassay that is based on previously published method 
[22]. Murine hepatoma Hepa1c1c7 cells were grown as monolayer in α-MEM supplemented with 10% (v/v) of heat-
and charcoal-inactivated fetal bovine serum. Cells were routinely maintained in a humidified incubator at 37 °C, 5% 
CO2. For each experiment, cells (10,000 per well) were seeded onto 96-well plates and incubated for 24 h to form a 
sub-confluent monolayers. After 24 h, cell monolayers were treated with either vehicle (DMSO at 0.1%, v/v) or 
serial dilutions (0.78-100 µM) of the compounds in octuplet wells. Treated cells were incubated for a further 48 h. 
At the end of the 48 h exposure period, cells were lysed for 30 min at 25 °C in digitonin (0.8 g/L, pH 7.8). The 
specific activity of NQO1 was evaluated in cell lysates using menadione as a substrate. Protein concentrations were 
determined in each well by the BCA protein assay (Thermo Scientific). Sulforaphane, a potent NQO1 inducer was 
used as a positive control. 
 
RESULTS AND DISCUSSION 
 
Seven known methylated flavonols were identified by comparing their spectral data with published data as 5,7-
dihydroxy-3,3',4'-trimethoxyflavone (1) [23], 5,4`-dihydroxy-3,6,7,3`-tetramethoxyflavone (Chrysosplenetin) (2) 
[24-26], 5,4`-dihydroxy-3,7-dimethoxyflavone (3) [27], Centaureidin (4) [28-30], 5,7-dihydroxy-3,6,3',4'-
tetramethoxyflavone (bonanzin) (5) [31], 5,3`,4`-trihydroxy-3,6,7-trimethoxyflavone (chrysosplenol-D) (6) [32, 33], 
and 5-Hydroxy-3,6,7,3`,4`,-pentamethoxy flavones (artemetin) (7) [34, 35]. It is note worthy that three of them are 
isolated for the first time from this genus (1-3). The structure formulae of the isolated flavonoid are displayed in 
Fig.1. The yield of the isolated compounds permits only the biological testing of three compounds 1, 5 and 7. 
 
Flavonoids are comprising a wide class of phytochemicals with diverse health benefits against several diseases such 
as cronary heart disease and cancer [22, 36]. In the present study we tested the potential of three of the isolated 
flavones for their potential to induce the activity of the chemopreventive enzyme NQO1. Compound 1 showed a 
pronounced dose-dependent induction of NQO1 with a CD value of 7.0 µM and a magnitude of induction of 3.3 fold 
over that of vehicle control at the highest tested concentration (100 µM). However, both compound 5 and compound 
7 were unable to induce NQO1 enzymatic activity at the tested concentration range (Fig.2). 
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Fig. 1 Chemical structure of the isolated flavonoid compounds 1-7 
 
 
 
Ahmed R. Hamed et al  J. Chem. Pharm. Res., 2016, 8(3):788-793 
______________________________________________________________________________ 
792 
Compound CD (µM)
1 7.00
5 >100
7 >100
 
Fig. 2 NQO1 inducer activity of compounds 1, 5 and 7. Monolayers of Hepa1c1c7 cells were treated with increasing concentrations as 
indicated of compound 1, 5 or 7 for 48 h and analysed for NQO1 inducer activity as described in the Experimental Section. Data are 
means of octuplet measurement. CD value is the concentration needed to double the NQO1 activity of the vehicle control (0.1% DMSO) 
 
Comparing the structures of the three tested compounds (Fig.1), the inducer activity of compound 1 could be largely 
correlated with the free hydroxyl groups at C-5 and C-7 of the A-ring of its flavones structure. However, the inducer 
activity is diminished by methoxylation of C-6 (compound 5) and additional methylation of the hydroxyl group at C-
7 (compound 7). It is also obvious that substitutions at B-ring of the flavones structure of these compounds have no 
effect on the NQO1 inducer potency of the flavones. These structure–activity relationships are in agreement with 
previous reports that concluded that substitutions at B-ring of a flavone by hydroxylation and/or methoxylation have 
no effect on the activity of the compound as NQO1 inducer [37, 38]. The muted NQO1 inducion (compound 5 and 
compound 7) due to the methoxylation at C-6 or both C-6 and C-7 is supported with the previous report of Tsuji and 
coworkers who analysed the structure-activity relationship of 37 flavonoids as indirect antioxidants in the same in 
vitro  murine model of NQO1 induction [38]. 
 
CONCLUSION 
 
The fractionation of CH2Cl2/MeOH (1:1) extract of C. montanus afforded 7 methoxylated flavonoids (1-7), three of 
which are isolated for the first time from the genus. One of three tested compounds induced the chemopreventive 
enzyme NQO1 in Hepa1c1c7 cells. The study confirmed the structure prerequisite of the substitutions at the 
flavonoid A-ring for the NQO1 inducer activity. 
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